Crown Electrokinetics Corp. Common Stock
CRKN
CRKN was delisted on the 4th of March, 2025.
1 hedge funds and large institutions have $417K invested in Crown Electrokinetics Corp. Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
35% less capital invested
Capital invested by funds: $645K → $417K (-$228K)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
P
Pitcairn
Conshohocken,
Pennsylvania
|
-$96K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$40K |
| 3 |
Jane Street
New York
|
-$11K |
| 4 |
HF
HRT Financial
New York
|
-$9K |
| 5 |
VF
Virtu Financial
New York
|
-$9K |
CRKN Hedge Fund Activity: Q4 2022 in Review
1 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Crown Electrokinetics Corp. Common Stock (CRKN) for Q4 2022, worth a combined $417K — down 35% from $645K a quarter earlier.
Fund positioning in CRKN was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Pitcairn, cutting an estimated $96K.
- 1 institutional investor held Crown Electrokinetics Corp. Common Stock (CRKN) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $417K of Crown Electrokinetics Corp. Common Stock stock for Q4 2022, down 35% quarter-over-quarter.
- 0 funds opened new Crown Electrokinetics Corp. Common Stock positions in Q4 2022 and 0 closed out.
- The largest Crown Electrokinetics Corp. Common Stock seller in Q4 2022 was Pitcairn, an estimated $96K sold.
Based on aggregated 13F filings for Q4 2022.